vs
Astrana Health, Inc.(ASTH)与STEVEN MADDEN, LTD.(SHOO)财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是STEVEN MADDEN, LTD.的1.3倍($950.5M vs $749.8M),STEVEN MADDEN, LTD.净利率更高(3.3% vs 0.7%,领先2.6%),Astrana Health, Inc.同比增速更快(42.9% vs 29.5%),STEVEN MADDEN, LTD.自由现金流更多($80.8M vs $-6.0M),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs 16.7%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
Steven Madden, Ltd.是一家上市时尚企业,专注于鞋履及潮流配饰的设计与营销,总部位于纽约长岛市。旗下拥有Dolce Vita、Betsey Johnson、Blondo、BB Dakota、Mad Love等品牌,同时获得Anne Klein、Superga等品牌的授权开展相关业务。
ASTH vs SHOO — 直观对比
营收规模更大
ASTH
是对方的1.3倍
$749.8M
营收增速更快
ASTH
高出13.3%
29.5%
净利率更高
SHOO
高出2.6%
0.7%
自由现金流更多
SHOO
多$86.8M
$-6.0M
两年增速更快
ASTH
近两年复合增速
16.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $749.8M |
| 净利润 | $6.6M | $24.7M |
| 毛利率 | — | 42.6% |
| 营业利润率 | 1.9% | 4.8% |
| 净利率 | 0.7% | 3.3% |
| 营收同比 | 42.9% | 29.5% |
| 净利润同比 | 184.4% | -34.8% |
| 每股收益(稀释后) | $0.12 | $0.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
SHOO
| Q4 25 | $950.5M | $749.8M | ||
| Q3 25 | $956.0M | $664.2M | ||
| Q2 25 | $654.8M | $556.1M | ||
| Q1 25 | $620.4M | $551.4M | ||
| Q4 24 | $665.2M | $578.8M | ||
| Q3 24 | $478.7M | $621.2M | ||
| Q2 24 | $486.3M | $521.7M | ||
| Q1 24 | $404.4M | $550.6M |
净利润
ASTH
SHOO
| Q4 25 | $6.6M | $24.7M | ||
| Q3 25 | $373.0K | $20.5M | ||
| Q2 25 | $9.4M | $-38.7M | ||
| Q1 25 | $6.7M | $41.3M | ||
| Q4 24 | $-7.8M | $37.8M | ||
| Q3 24 | $16.1M | $55.3M | ||
| Q2 24 | $19.2M | $36.9M | ||
| Q1 24 | $14.8M | $44.6M |
毛利率
ASTH
SHOO
| Q4 25 | — | 42.6% | ||
| Q3 25 | — | 41.8% | ||
| Q2 25 | — | 40.6% | ||
| Q1 25 | — | 41.0% | ||
| Q4 24 | — | 40.7% | ||
| Q3 24 | — | 41.8% | ||
| Q2 24 | — | 41.6% | ||
| Q1 24 | — | 40.8% |
营业利润率
ASTH
SHOO
| Q4 25 | 1.9% | 4.8% | ||
| Q3 25 | 2.0% | 4.7% | ||
| Q2 25 | 3.1% | -7.2% | ||
| Q1 25 | 3.3% | 9.7% | ||
| Q4 24 | 0.1% | 8.1% | ||
| Q3 24 | 5.9% | 12.0% | ||
| Q2 24 | 6.2% | 9.0% | ||
| Q1 24 | 7.5% | 10.3% |
净利率
ASTH
SHOO
| Q4 25 | 0.7% | 3.3% | ||
| Q3 25 | 0.0% | 3.1% | ||
| Q2 25 | 1.4% | -7.0% | ||
| Q1 25 | 1.1% | 7.5% | ||
| Q4 24 | -1.2% | 6.5% | ||
| Q3 24 | 3.4% | 8.9% | ||
| Q2 24 | 3.9% | 7.1% | ||
| Q1 24 | 3.7% | 8.1% |
每股收益(稀释后)
ASTH
SHOO
| Q4 25 | $0.12 | $0.33 | ||
| Q3 25 | $0.01 | $0.29 | ||
| Q2 25 | $0.19 | $-0.56 | ||
| Q1 25 | $0.14 | $0.57 | ||
| Q4 24 | $-0.14 | $0.49 | ||
| Q3 24 | $0.33 | $0.77 | ||
| Q2 24 | $0.40 | $0.49 | ||
| Q1 24 | $0.31 | $0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $112.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $866.4M |
| 总资产 | $2.2B | $1.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
SHOO
| Q4 25 | $429.5M | $112.4M | ||
| Q3 25 | $463.4M | $140.0K | ||
| Q2 25 | $342.1M | $111.9M | ||
| Q1 25 | $260.9M | $147.2M | ||
| Q4 24 | $290.8M | $203.4M | ||
| Q3 24 | $350.3M | $11.1M | ||
| Q2 24 | $327.7M | $192.2M | ||
| Q1 24 | $337.3M | $143.1M |
股东权益
ASTH
SHOO
| Q4 25 | $779.3M | $866.4M | ||
| Q3 25 | $775.5M | $850.8M | ||
| Q2 25 | $765.5M | $833.2M | ||
| Q1 25 | $745.4M | $875.3M | ||
| Q4 24 | $712.7M | $847.7M | ||
| Q3 24 | $704.6M | $833.9M | ||
| Q2 24 | $678.9M | $808.3M | ||
| Q1 24 | $653.5M | $825.2M |
总资产
ASTH
SHOO
| Q4 25 | $2.2B | $1.9B | ||
| Q3 25 | $2.2B | $2.0B | ||
| Q2 25 | $1.4B | $1.9B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.3B | $1.4B | ||
| Q1 24 | $1.2B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $91.1M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $80.8M |
| 自由现金流率自由现金流/营收 | -0.6% | 10.8% |
| 资本支出强度资本支出/营收 | 0.3% | 1.4% |
| 现金转化率经营现金流/净利润 | -0.44× | 3.70× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $119.5M |
8季度趋势,按日历期对齐
经营现金流
ASTH
SHOO
| Q4 25 | $-2.9M | $91.1M | ||
| Q3 25 | $10.0M | $23.4M | ||
| Q2 25 | $90.9M | $66.5M | ||
| Q1 25 | $16.6M | $-18.8M | ||
| Q4 24 | $-10.9M | $103.9M | ||
| Q3 24 | $34.0M | $444.0K | ||
| Q2 24 | $23.2M | $109.5M | ||
| Q1 24 | $6.0M | $-15.7M |
自由现金流
ASTH
SHOO
| Q4 25 | $-6.0M | $80.8M | ||
| Q3 25 | $7.4M | $8.6M | ||
| Q2 25 | $89.5M | $58.8M | ||
| Q1 25 | $13.6M | $-28.7M | ||
| Q4 24 | $-13.5M | $94.6M | ||
| Q3 24 | $31.7M | $-6.9M | ||
| Q2 24 | $20.4M | $104.2M | ||
| Q1 24 | $5.6M | $-19.7M |
自由现金流率
ASTH
SHOO
| Q4 25 | -0.6% | 10.8% | ||
| Q3 25 | 0.8% | 1.3% | ||
| Q2 25 | 13.7% | 10.6% | ||
| Q1 25 | 2.2% | -5.2% | ||
| Q4 24 | -2.0% | 16.3% | ||
| Q3 24 | 6.6% | -1.1% | ||
| Q2 24 | 4.2% | 20.0% | ||
| Q1 24 | 1.4% | -3.6% |
资本支出强度
ASTH
SHOO
| Q4 25 | 0.3% | 1.4% | ||
| Q3 25 | 0.3% | 2.2% | ||
| Q2 25 | 0.2% | 1.4% | ||
| Q1 25 | 0.5% | 1.8% | ||
| Q4 24 | 0.4% | 1.6% | ||
| Q3 24 | 0.5% | 1.2% | ||
| Q2 24 | 0.6% | 1.0% | ||
| Q1 24 | 0.1% | 0.7% |
现金转化率
ASTH
SHOO
| Q4 25 | -0.44× | 3.70× | ||
| Q3 25 | 26.69× | 1.14× | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | -0.46× | ||
| Q4 24 | — | 2.75× | ||
| Q3 24 | 2.11× | 0.01× | ||
| Q2 24 | 1.21× | 2.96× | ||
| Q1 24 | 0.40× | -0.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SHOO
暂无分部数据